STX-1150
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STX-1150, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) [Phase 1]